Cover Image

Impact of short-term discontinuation of ivermectin-based chemoprevention on onchocerciasis transmission in endemic settings with long history of mass drug administration.

<h4>Background</h4>The control of onchocerciasis currently relies on annual distribution of single dose ivermectin. Because ivermectin has minimal effects on the adult parasite, mass drug administration (MDA) campaigns against onchocerciasis require at least 15 years of annual uninterrup...

Full description

Saved in:

Bibliographic Details
Main Authors:	Arnauld Efon-Ekangouo (Author), Hugues C Nana-Djeunga (Author), Narcisse Nzune-Toche (Author), Raïssa Dongmo-Yemele (Author), Jean Bopda (Author), Viviane Ongbassomben (Author), Laurentine Sumo (Author), Anne Geiger (Author), Thomas B Nutman (Author), Joseph Kamgno (Author)
Format:	Book
Published:	Public Library of Science (PLoS), 2023-04-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

High infection rates for onchocerciasis and soil-transmitted helminthiasis in children under five not receiving preventive chemotherapy: a bottleneck to elimination
by: Hugues C. Nana-Djeunga, et al.
Published: (2022)

Correction to: High infection rates for onchocerciasis and soil-transmitted helminthiasis in children under five not receiving preventive chemotherapy: a bottleneck to elimination
by: Hugues C. Nana-Djeunga, et al.
Published: (2022)

Reproductive status of Onchocerca volvulus after ivermectin treatment in an ivermectin-naïve and a frequently treated population from Cameroon.
by: Hugues C Nana-Djeunga, et al.
Published: (2014)

Relationship between skin snip and Ov16 ELISA: Two diagnostic tools for onchocerciasis in a focus in Cameroon after two decades of ivermectin-based preventive chemotherapy.
by: Linda Djune-Yemeli, et al.
Published: (2022)

Adherence to ivermectin is more associated with perceptions of community directed treatment with ivermectin organization than with onchocerciasis beliefs.
by: Fanny Nadia Dissak-Delon, et al.
Published: (2017)

Evaluation of Lymphatic Filariasis and Onchocerciasis in Three Senegalese Districts Treated for Onchocerciasis with Ivermectin.
by: Nana O Wilson, et al.
Published: (2016)

Dynamics of Onchocerca volvulus microfilarial densities after ivermectin treatment in an ivermectin-naïve and a multiply treated population from Cameroon.
by: Sébastien D S Pion, et al.
Published: (2013)

Can ivermectin mass treatments eliminate onchocerciasis in Africa?
by: Winnen M., et al.
Published: (2002)

Can ivermectin mass treatments eliminate onchocerciasis in Africa?
by: M. Winnen, et al.

The impact of ivermectin on onchocerciasis in villages co-endemic for lymphatic filariasis in an area of onchocerciasis recrudescence in Burkina Faso.
by: Achille S Nikièma, et al.
Published: (2021)

Would ivermectin for malaria control be beneficial in onchocerciasis-endemic regions?
by: Joseph Nelson Siewe Fodjo, et al.
Published: (2019)

Ivermectin and doxycycline treatments against Onchocerciasis: Adaptations and impact among semi-nomadic population in Massangam Health District, Cameroon.
by: Rogers Nditanchou, et al.
Published: (2023)

Correction: Ivermectin and doxycycline treatments against Onchocerciasis: Adaptations and impact among semi-nomadic population in Massangam Health District, Cameroon.
by: Rogers Nditanchou, et al.
Published: (2024)

Uncertainty surrounding projections of the long-term impact of ivermectin treatment on human onchocerciasis.
by: Hugo C Turner, et al.
Published: (2013)

Interruption of infection transmission in the onchocerciasis focus of Ecuador leading to the cessation of ivermectin distribution.
by: Raquel Lovato, et al.
Published: (2014)

Progress towards global elimination of lymphatic filariasis
by: Joseph Kamgno, et al.
Published: (2020)

Impact of five annual rounds of mass drug administration with ivermectin on onchocerciasis in Sierra Leone
by: Joseph B. Koroma, et al.
Published: (2018)

Evaluating the impact of alternative intervention strategies in accelerating onchocerciasis elimination in an area of persistent transmission in the West Region of Cameroon.
by: Kareen Atekem, et al.
Published: (2022)

Repurposed automated handheld counter as a point-of-care tool to identify individuals 'at risk' of serious post-ivermectin encephalopathy.
by: Sasisekhar Bennuru, et al.
Published: (2014)

Assessment of the performance of community-directed treatment with ivermectin strategy for the control and elimination of onchocerciasis in Edo State, Nigeria
by: Amenze Oritsemofe Onowhakpor, et al.
Published: (2017)

The Mbam drainage system and onchocerciasis transmission post ivermectin mass drug administration (MDA) campaign, Cameroon.
by: Raphael Awah Abong, et al.
Published: (2021)

The cost of annual versus biannual community-directed treatment of onchocerciasis with ivermectin: Ghana as a case study.
by: Hugo C Turner, et al.
Published: (2013)

Onchocerciasis: Target product profiles of in vitro diagnostics to support onchocerciasis elimination mapping and mass drug administration stopping decisions.
by: Marco A Biamonte, et al.
Published: (2022)

Prevalence of epilepsy in the onchocerciasis endemic middle belt of Ghana after 27 years of mass drug administration with ivermectin
by: Kenneth Bentum Otabil, et al.
Published: (2023)

Impact of ivermectin and vector control on onchocerciasis transmission in Togo: Assessing the empirical evidence on trends in infection and entomological indicators.
by: Natalie V S Vinkeles Melchers, et al.
Published: (2024)

Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal.
by: Lamine Diawara, et al.
Published: (2009)

Immunoepidemiological profiling of onchocerciasis patients reveals associations with microfilaria loads and ivermectin intake on both individual and community levels.
by: Kathrin Arndts, et al.
Published: (2014)

Mass Administration of Ivermectin for the Elimination of Onchocerciasis Significantly Reduced and Maintained Low the Prevalence of Strongyloides stercoralis in Esmeraldas, Ecuador.
by: Mariella Anselmi, et al.
Published: (2015)

Genome-wide analysis of ivermectin response by Onchocerca volvulus reveals that genetic drift and soft selective sweeps contribute to loss of drug sensitivity.
by: Stephen R Doyle, et al.
Published: (2017)

Ivermectin as an adjuvant to anti-epileptic treatment in persons with onchocerciasis-associated epilepsy: A randomized proof-of-concept clinical trial.
by: Michel Mandro, et al.
Published: (2020)

Proof-of-principle of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: final results of a study in Mali and Senegal.
by: Mamadou O Traore, et al.
Published: (2012)

African Program for Onchocerciasis Control 1995-2010: Impact of Annual Ivermectin Mass Treatment on Off-Target Infectious Diseases.
by: Stanimira P Krotneva, et al.
Published: (2015)

Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa.
by: Peter U Fischer, et al.
Published: (2017)

Low prevalence of epilepsy and onchocerciasis after more than 20 years of ivermectin treatment in the Imo River Basin in Nigeria
by: Joseph N. F. Siewe, et al.
Published: (2019)

Epidemiology of onchocerciasis-associated epilepsy in the Mbam and Sanaga river valleys of Cameroon: impact of more than 13 years of ivermectin
by: Joseph Nelson Siewe Fodjo, et al.
Published: (2018)

A Knowledge, Attitudes and Practices Survey Conducted Three Years after Halting Ivermectin Mass Treatment for Onchocerciasis in Guatemala.
by: Frank O Richards, et al.
Published: (2016)

Serious limitations of the current strategy to control Soil-Transmitted Helminths and added value of Ivermectin/Albendazole mass administration: A population-based observational study in Cameroon.
by: Linda Djune-Yemeli, et al.
Published: (2020)

Report of the first international workshop on onchocerciasis-associated epilepsy
by: Robert Colebunders, et al.
Published: (2018)

Correction: Ivermectin and doxycycline treatments against Onchocerciasis: Adaptations and impact among semi-nomadic population in Massangam Health District, Cameroon
Published: (2024)

A randomized, open-label study of the tolerability and efficacy of one or three daily doses of ivermectin plus diethylcarbamazine and albendazole (IDA) versus one dose of ivermectin plus albendazole (IA) for treatment of onchocerciasis.
by: Nicholas O Opoku, et al.
Published: (2023)